Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-09-03
1995-10-24
Rizzo, Nicholas
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540222, C07D50122, A61K 31545
Patent
active
054610435
ABSTRACT:
Enterally absorbable diastereomers of 1-(isopropoxycarbonyloxy)ethyl (6R,7R)-7-[2-(2-aminothiazol-4-yl)-2-(Z)-(methoxyimino)acetamido]-3-(metho xymethyl)-3-cephem-4-carboxylate of the formula I ##STR1## and their physiologically acceptable salts and also diastereomerically pure salts of the compounds of the formula II ##STR2## where HX is a mono- or polybasic acid and where X is an inorganic or organic physiologically acceptable anion, and a process for the preparation of these compounds of the formula I or II, which comprises first precipitating the more sparingly soluble diastereomer of the formula IV in the mixing together of 1 equivalent of a solution of the diastereomer mixture of the formula III with 0.2-2 equivalents of a solution of the acid component HY and separating it off by filtration, then precipitating the more readily soluble diastereomer of the formula IV from the filtration solution, it being possible for the acid component HY to be identical or different in the consecutive partial steps and any desired sequence of addition of different acid components HY being possible, and optionally further purifying the obtained salts by crystallization, are described.
REFERENCES:
patent: 4098888 (1978-07-01), Ochiai et al.
patent: 4203899 (1980-05-01), Ochiai et al.
patent: 4205180 (1980-05-01), Ochiai et al.
patent: 4264595 (1981-04-01), Numata et al.
patent: 4278793 (1981-07-01), Durckheimer et al.
patent: 4283396 (1981-08-01), Heymes et al.
patent: 4298606 (1981-11-01), Ochiai et al.
patent: 4355160 (1982-10-01), Ochiai et al.
patent: 4409215 (1983-10-01), Takaya et al.
patent: 4462999 (1984-07-01), Takaya et al.
patent: 4483855 (1984-11-01), Nakao et al.
patent: 4486425 (1992-12-01), Nakao et al.
patent: 4514565 (1985-04-01), Ochiai et al.
patent: 4668783 (1987-05-01), Ochiai et al.
patent: 4904652 (1990-02-01), Takaya et al.
patent: 4912212 (1990-03-01), Ochiai et al.
patent: 4973684 (1990-11-01), Ochiai et al.
patent: 4992431 (1991-03-01), Heymes et al.
patent: 5026695 (1991-06-01), Takaya et al.
patent: 5063224 (1991-11-01), Mosher et al.
patent: 5100887 (1992-03-01), Adam et al.
patent: 5306717 (1994-04-01), Adam et al.
"Cefpodoxime Proxetil", Drugs of the Future, 14(1):73-74 (1989).
"SCE-2174", Drugs of the Future, 13(3):231-233 (1988).
"Cefuroxime Axetil", Drugs of the Future, 10(2):112-113 (1985).
"Antibiotic Activity of CL 118,673, a New Oral Cephalosporin", N. A. Kuck et al., Recent Advances In Chemotherapy, Proceedings of the 14th Int'l. Congress of Chemotherapy, Antimicrobial Section 2, pp. 1137-1138, (1985).
"Improved Synthesis of an Ester-Type Prodrug, 1-Acetoxyethyl 7-[(Z)-2-(2-Aminothiazol-4-yl)-2-Hydroxyiminoacetamido]-3-[(Z)-1-Propenyl] -3-Cephem-4-Carboxylate (BMY-28271)", Hajime Kamachi et al., The Journal of Antibiotics, vol. XLIII(12):1564-1572 (1990).
"Orally Active 1-(Cyclohexyloxycarbonyloxy)alkyl Ester Prodrugs of Cefotiam", Tatsuo Nishimura et al, The Journal of Antibiotics, vol. XL(1):81-90 (1987).
".beta.-Lactam compounds", Chemical Abstracts, 102:220658k (1985).
"Cephalosporin devivatives", Chemical Abstracts, 102:220657j (1985).
Defossa Elisabeth
Fischer Gerd
Gerlach Uwe
Horlein Rolf
Isert Dieter
Hoechst Aktiengesellschaft
Rizzo Nicholas
LandOfFree
Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carbo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carbo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carbo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1886752